NBE Therapeutics (NBE) a wholly owned subsidiary of Boehringer Ingelheim, officially opened its new ADC R&D facility in Basel ...

Boehringer Ingelheim is pumping funds into the still-hot antibody-drug conjugate space, committing 27 million Swiss francs ...

Wealth rating firm Forbes states that most billionaires worldwide fall within the age range of 50 to 79. However, 12% of billionaires are younger than this range, achieving billionaire status by the ...

The term billionaire is not a small feat, and most times can be an accumulation of one's lifetime's work yielding in their ...

With concerns mounting and speculation swirling, the particulars of President Donald Trump’s much-touted “Liberation Day” ...

New evidence suggests that factors other than the percentage of weight loss should be considered when determining the success ...

The AI in Life Science Market is anticipated to experience a remarkable compound annual growth rate (CAGR) of around 25% in ...

Becoming a billionaire is not a walk in the park as majority of the wealthy elites spend their lifetime chasing that ...

Co-production deals with adalimumab biosimilar manufacturers and PBMs have increased biosimilar adoption, but this ...

The National Comprehensive Cancer Network® (NCCN®) and the NCCN Foundation® proudly announce four recipients for the 2025 NCCN Foundation Young Investigator Awards (YIA). These awards provide ...

For patients with chronic obstructive pulmonary disorder (COPD), long-term inhaled corticosteroid (ICS) treatment is associated with increased rates of adverse composite and specific individual ...

Kanazawa University and colleagues have developed a promising new approach to cancer treatment. By using tiny, naturally occurring particles called extracellular vesicles (EVs), they ...